Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor: A Proof of Principle Trial

Clinical trial NCT01372644 · COMPLETED

Trial details

NCT number: NCT01372644
Sponsor: NYU Langone Health
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Atypical Ductal Breast Hyperplasia Lobular Carcinoma in Situ (LCIS)Atypical Lobular Hyperplasia (ALH) of Breast

Start date: 2007-11-01
Primary completion: 2010-12-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.